Genetic mutations and polymorphisms can play a significant role in MDR. Mutations in genes encoding drug targets or transporters can confer resistance. Furthermore, genetic factors can influence the expression of efflux pumps and other resistance mechanisms. Understanding the pharmacogenomics of MDR can aid in developing personalized medicine approaches to overcome resistance.
